{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:58:18Z","timestamp":1794650298800,"version":"4.9.1"},"reference-count":41,"publisher":"American Chemical Society (ACS)","issue":"3","license":[{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["LP120200557"],"award-info":[{"award-number":["LP120200557"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1092789"],"award-info":[{"award-number":["APP1092789"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000947","name":"Australian Cancer Research Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Novel antimalarial therapeutics that target multiple stages of the parasite lifecycle are urgently required to tackle the emerging problem of resistance with current drugs. Here, we describe the optimization of the 2-anilino quinazoline class as antimalarial agents. The class, identified from publicly available antimalarial screening data, was optimized to generate lead compounds that possess potent antimalarial activity against P. falciparum parasites comparable to the known antimalarials, chloroquine and mefloquine. During the optimization process, we defined the functionality necessary for activity and improved in vitro metabolism and solubility. The resultant lead compounds possess potent activity against a multidrug resistant strain of P. falciparum and arrest parasites at the ring phase of the asexual stage and also gametocytogensis. Finally, we show that the lead compounds are orally efficacious in a 4 day murine model of malaria disease burden.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6b01673","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T15:26:23Z","timestamp":1484234783000},"page":"1171-1188","source":"Crossref","is-referenced-by-count":68,"title":["Optimization of\n2-Anilino 4-Amino Substituted\nQuinazolines into Potent Antimalarial Agents with Oral in Vivo Activity"],"prefix":"10.1021","volume":"60","author":[{"given":"Paul R.","family":"Gilson","sequence":"first","affiliation":[{"name":"Macfarlane Burnet Institute for Medical Research and Public Health , , ,","place":["Melbourne, Australia, 3004"]},{"name":"Monash University , , ,","place":["Clayton, Victoria, Australia, 3800"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Tan","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research , ,","place":["Parkville, Australia, 3052"]},{"name":"The University of Melbourne , , ,","place":["Parkville, Australia, 3010"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate E.","family":"Jarman","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research , ,","place":["Parkville, Australia, 3052"]},{"name":"The University of Melbourne , , ,","place":["Parkville, Australia, 3010"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kym N.","family":"Lowes","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research , ,","place":["Parkville, Australia, 3052"]},{"name":"The University of Melbourne , , ,","place":["Parkville, Australia, 3010"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan M.","family":"Curtis","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research , ,","place":["Parkville, Australia, 3052"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Nguyen","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research , ,","place":["Parkville, Australia, 3052"]},{"name":"The University of Melbourne , , ,","place":["Parkville, Australia, 3010"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian E.","family":"Di Rago","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research , ,","place":["Parkville, Australia, 3052"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley E.","family":"Bullen","sequence":"additional","affiliation":[{"name":"Macfarlane Burnet Institute for Medical Research and Public Health , , ,","place":["Melbourne, Australia, 3004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Prinz","sequence":"additional","affiliation":[{"name":"Macfarlane Burnet Institute for Medical Research and Public Health , , ,","place":["Melbourne, Australia, 3004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Duffy","sequence":"additional","affiliation":[{"name":"Griffith University , , , ,","place":["Nathan, Queensland, Australia, 4111"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Baell","sequence":"additional","affiliation":[{"name":"Monash University , , , ,","place":["Parkville, Victoria, Australia, 3052"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2353-9258","authenticated-orcid":true,"given":"Craig A.","family":"Hutton","sequence":"additional","affiliation":[{"name":"University of Melbourne , , , ,","place":["Parkville, Victoria, Australia, 3010"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Jousset Subroux","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research , ,","place":["Parkville, Australia, 3052"]},{"name":"The University of Melbourne , , ,","place":["Parkville, Australia, 3010"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan S.","family":"Crabb","sequence":"additional","affiliation":[{"name":"The University of Melbourne , , ,","place":["Parkville, Australia, 3010"]},{"name":"Macfarlane Burnet Institute for Medical Research and Public Health , , ,","place":["Melbourne, Australia, 3004"]},{"name":"Monash University , , ,","place":["Clayton, Victoria, Australia, 3800"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky M.","family":"Avery","sequence":"additional","affiliation":[{"name":"Griffith University , , , ,","place":["Nathan, Queensland, Australia, 4111"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan F.","family":"Cowman","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research , ,","place":["Parkville, Australia, 3052"]},{"name":"The University of Melbourne , , ,","place":["Parkville, Australia, 3010"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-1048","authenticated-orcid":true,"given":"Brad E.","family":"Sleebs","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research , ,","place":["Parkville, Australia, 3052"]},{"name":"The University of Melbourne , , ,","place":["Parkville, Australia, 3010"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2017,1,12]]},"reference":[{"key":"2026090218200950600_cit1","unstructured":"World Malaria\nReport 2016, World Health Organisation, Geneva. http:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2016\/report\/en\/23 (accessed Dec 23, 2016)."},{"key":"2026090218200950600_cit2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2001.64.97","article-title":"The neglected burden\nof Plasmodium vivax malaria","volume":"64","author":"Mendis","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"2026090218200950600_cit3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/465297a","article-title":"Drug discovery:\nPriming the antimalarial pipeline","volume":"465","author":"Fidock","year":"2010","journal-title":"Nature"},{"key":"2026090218200950600_cit4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin\nresistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N.\nEngl. J. Med."},{"key":"2026090218200950600_cit5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/1475-2875-12-408","article-title":"Identification of inhibitors of Plasmodium falciparum gametocyte development","volume":"12","author":"Duffy","year":"2013","journal-title":"Malar. J."},{"key":"2026090218200950600_cit6","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"a. Imaging of Plasmodium liver stages to drive next-generation antimalarial\ndrug discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"key":"2026090218200950600_cit7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature09099","article-title":"Chemical\ngenetics of Plasmodium falciparum","volume":"465","author":"Guiguemde","year":"2010","journal-title":"Nature"},{"key":"2026090218200950600_cit8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands\nof chemical starting points for antimalarial\nlead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"2026090218200950600_cit9","doi-asserted-by":"publisher","first-page":"9059","DOI":"10.1073\/pnas.0802982105","article-title":"In silico activity\nprofiling reveals the mechanism of action of antimalarials discovered\nin a high-throughput screen","volume":"105","author":"Plouffe","year":"2008","journal-title":"Proc. Natl. Acad.\nSci. U. S. A."},{"key":"2026090218200950600_cit10","doi-asserted-by":"publisher","first-page":"e62906","DOI":"10.1371\/journal.pone.0062906","article-title":"The open access malaria box: a drug discovery catalyst\nfor neglected diseases","volume":"8","author":"Spangenberg","year":"2013","journal-title":"PLoS One"},{"key":"2026090218200950600_cit11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1021\/jm00211a020","article-title":"Quantitative structure-activity\nrelation of antimalarial and dihydrofolate reductase inhibition by\nquinazolines and 5-substituted benzyl-2,4-diaminopyrimidines","volume":"20","author":"Hansch","year":"1977","journal-title":"J. Med. Chem."},{"key":"2026090218200950600_cit12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1021\/jm401760c","article-title":"2,4-Diaminothienopyrimidines\nas orally active antimalarial agents","volume":"57","author":"Gonzalez Cabrera","year":"2014","journal-title":"J. Med.\nChem."},{"key":"2026090218200950600_cit13","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1038\/ncomms7715","article-title":"Triaminopyrimidine is a fast-killing\nand long-acting antimalarial clinical candidate","volume":"6","author":"Hameed","year":"2015","journal-title":"Nat. Commun."},{"key":"2026090218200950600_cit14","doi-asserted-by":"publisher","first-page":"16708","DOI":"10.1073\/pnas.1205414109","article-title":"Small-molecule\nhistone methyltransferase inhibitors display rapid antimalarial activity\nagainst all blood stage forms in Plasmodium falciparum","volume":"109","author":"Malmquist","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026090218200950600_cit15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1021\/jm00134a002","article-title":"Synthesis and antimalarial\neffects of N2-aryl-N4-[(dialkylamino)alkyl]- and\nN4-aryl-N2-[(dialkylamino)alkyl]-2,4-quinazolinediamines","volume":"24","author":"Elslager","year":"1981","journal-title":"J. Med. Chem."},{"key":"2026090218200950600_cit18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4269\/ajtmh.1993.48.205","article-title":"Measurement of the\nlactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia","volume":"48","author":"Makler","year":"1993","journal-title":"Am. J. Trop.\nMed. Hyg."},{"key":"2026090218200950600_cit19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1021\/tx3003824","article-title":"Reactive\nmetabolites in the biotransformation of molecules containing a furan\nring","volume":"26","author":"Peterson","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"2026090218200950600_cit20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/oxfordjournals.jbchem.a130298","article-title":"Enzymatic studies on\nthe metabolism of the tetrahydrofurfuryl\nmercaptan moiety of thiamine tetrahydrofurfuryl disulfide: III. Oxidative\ncleavage of the tetrahydrofuran moiety","volume":"74","author":"Fujita","year":"1973","journal-title":"J. Biochem."},{"key":"2026090218200950600_cit21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0009-2797(91)90036-7","article-title":"Bioactivation of 4-fluorinated\nanilines to benzoquinoneimines\nas primary reaction products","volume":"77","author":"Rietjens","year":"1991","journal-title":"Chem.-Biol. Interact."},{"key":"2026090218200950600_cit22","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1021\/tx900256y","article-title":"Bioactivation of the epidermal growth\nfactor receptor inhibitor Gefitinib: Implications for pulmonary and\nhepatic toxicities","volume":"22","author":"Li","year":"2009","journal-title":"Chem. Res. Toxicol."},{"key":"2026090218200950600_cit23","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/0006-2952(95)00043-Y","article-title":"The effect\nof varying halogen substituent patterns on the cytochrome P450 catalysed\ndehalogenation of 4-halogenated anilines to 4-aminophenol metabolites","volume":"49","author":"Cnubben","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"2026090218200950600_cit24","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1073\/pnas.91.3.1143","article-title":"Selection for mefloquine\nresistance\nin Plasmodium falciparum is linked to amplification\nof the pfmdr1 gene and cross-resistance to halofantrine and quinine","volume":"91","author":"Cowman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026090218200950600_cit25","doi-asserted-by":"publisher","first-page":"e1002132","DOI":"10.1371\/journal.pbio.1002132","article-title":"Targeting\nthe cell stress response of Plasmodium falciparum to overcome artemisinin resistance","volume":"13","author":"Dogovski","year":"2015","journal-title":"PLoS Biol."},{"key":"2026090218200950600_cit26","doi-asserted-by":"publisher","first-page":"e112571","DOI":"10.1371\/journal.pone.0112571","article-title":"Plasmodium falciparum transfected with ultra bright NanoLuc\nluciferase offers high sensitivity\ndetection for the screening of growth and cellular trafficking inhibitors","volume":"9","author":"Azevedo","year":"2014","journal-title":"PLoS One"},{"key":"2026090218200950600_cit27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrd1416","article-title":"Antimalarial\ndrug discovery: efficacy models for compound screening","volume":"3","author":"Fidock","year":"2004","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026090218200950600_cit28","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1016\/j.bmc.2016.05.025","article-title":"Synthesis,\nbiological evaluation,\nand physicochemical property assessment of 4-substituted 2-phenylaminoquinazolines\nas Mer tyrosine kinase inhibitors","volume":"24","author":"Wang","year":"2016","journal-title":"Bioorg. Med.\nChem."},{"key":"2026090218200950600_cit29","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.bmcl.2015.11.049","article-title":"Design and synthesis of novel selective anaplastic lymphoma kinase\ninhibitors","volume":"26","author":"Michellys","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026090218200950600_cit30","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1016\/j.bmc.2015.07.034","article-title":"Discovery and structure\nof a new inhibitor scaffold\nof the autophagy initiating kinase ULK1","volume":"23","author":"Lazarus","year":"2015","journal-title":"Bioorg.\nMed. Chem."},{"key":"2026090218200950600_cit31","doi-asserted-by":"publisher","first-page":"9480","DOI":"10.1021\/acs.jmedchem.5b01346","article-title":"Discovery\nof a first-in-class, potent, selective, and orally bioavailable inhibitor\nof the p97 AAA ATPase (CB-5083)","volume":"58","author":"Zhou","year":"2015","journal-title":"J. Med. Chem."},{"key":"2026090218200950600_cit32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/cmdc.201200520","article-title":"Structure-activity\nrelationship study reveals ML240 and ML241 as potent and selective\ninhibitors of p97 ATPase","volume":"8","author":"Chou","year":"2013","journal-title":"ChemMedChem"},{"key":"2026090218200950600_cit33","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1021\/jm00014a027","article-title":"Reversible inhibitors\nof the gastric (H+\/K+)-ATPase. 5. Substituted 2,4-diaminoquinazolines\nand thienopyrimidines","volume":"38","author":"Ife","year":"1995","journal-title":"J. Med. Chem."},{"key":"2026090218200950600_cit34","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1016\/j.bmcl.2015.07.030","article-title":"Discovery\nof novel potent and selective ligands for 5-HT2A receptor\nwith quinazoline scaffold","volume":"25","author":"Deng","year":"2015","journal-title":"Bioorg. Med. Chem.\nLett."},{"key":"2026090218200950600_cit35","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.bmc.2012.12.013","article-title":"Synthesis and biological evaluation of novel 2,4-disubstituted quinazoline\nanalogues as GPR119 agonists","volume":"21","author":"Pham","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"2026090218200950600_cit36","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0960-894X(00)00177-3","article-title":"Design, synthesis\nand SAR of a series\nof 2-substituted 4-amino-quinazoline neuropeptide Y Y5 receptor antagonists","volume":"10","author":"Rueeger","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026090218200950600_cit37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites\nin continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"2026090218200950600_cit38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejmech.2014.05.019","article-title":"Design, synthesis\nand molecular docking\nstudies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based\ntriazoles with potential anticancer activity","volume":"81","author":"Pingaew","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"2026090218200950600_cit39","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nprot.2016.056","article-title":"Large-scale\nproduction\nof Plasmodium falciparum gametocytes for malaria\ndrug discovery","volume":"11","author":"Duffy","year":"2016","journal-title":"Nat. Protoc."},{"key":"2026090218200950600_cit40","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1021\/ac9912247","article-title":"A high-throughput\nscreening method for the determination\nof aqueous drug solubility using laser nephelometry in microtiter\nplates","volume":"72","author":"Bevan","year":"2000","journal-title":"Anal. Chem."},{"key":"2026090218200950600_cit41","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","article-title":"Prediction\nof human clearance of twenty-nine drugs from hepatic microsomal intrinsic\nclearance data: an examination of in vitro half-life approach and\nnon-specific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab.\nDispos."},{"key":"2026090218200950600_cit42","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1002\/jps.22552","article-title":"PhRMA CPCDC initiative\non predictive models of human\npharmacokinetics, part 3: Comparative assessement of prediction methods\nof human clearance","volume":"100","author":"Ring","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"2026090218200950600_cit43","unstructured":"Calculator\nPlugins were used for structure property prediction and calculation,\nMarvinSketch 6.0.6, 2013, ChemAxon (http:\/\/www.chemaxon.com)."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6b01673","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/60\/3\/1171\/67033614\/acs.jmedchem.6b01673.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/60\/3\/1171\/67033614\/acs.jmedchem.6b01673.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:20:38Z","timestamp":1788387638000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/60\/3\/1171\/764626\/Optimization-of-2-Anilino-4-Amino-Substituted"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,12]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,1,12]]},"published-print":{"date-parts":[[2017,2,9]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01673","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01673.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01673.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01673.s003","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,12]]}}}